Rottinghaus Scott T. 内部人交易：近期 SEC Form 4 交易
过去 18 个月，Rottinghaus Scott T.（CIK 1942407）在 1 家公司共报告 6 笔 SEC Form 4 内部人交易（最近一笔 2026-08-10）。
| 日期 | 公司 | 身份 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-08-10 | ENANTA PHARMACEUTICALS INC (ENTA) | Chief Medical Officer | 卖出 | 1,467 | $19,570 |
| 2026-02-13 | ENANTA PHARMACEUTICALS INC (ENTA) | Chief Medical Officer | 买入 | 1,650 | $0 |
| 2026-02-13 | ENANTA PHARMACEUTICALS INC (ENTA) | Chief Medical Officer | 买入 | 5,225 | $0 |
| 2026-02-13 | ENANTA PHARMACEUTICALS INC (ENTA) | Chief Medical Officer | 卖出 | 3,413 | $48,635 |
| 2025-12-05 | ENANTA PHARMACEUTICALS INC (ENTA) | Chief Medical Officer | 卖出 | 798 | $11,356 |
| 2025-08-08 | ENANTA PHARMACEUTICALS INC (ENTA) | Chief Medical Officer | 卖出 | 2,217 | $15,497 |
来源：SEC Form 4 申报文件 · 截至 2026-08-10